Annual Drug Patent Expirations for DEXILANT+SOLUTAB
Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are eleven patents protecting this drug.
Drug patent litigation for DEXILANT SOLUTAB.
This drug has ninety-four patent family members in thirty-seven countries.
The generic ingredient in DEXILANT SOLUTAB is dexlansoprazole. Additional details are available on the dexlansoprazole profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
